- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 96,130 | 09.08.24 19:09:25 | +0,780 | +0,82% | 96,120 | 96,300 | 95,520 | 95,350 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 1.029,500 | 09.08.24 17:06:43 | +11,000 | +1,08% | 1.026,500 | 1.032,000 | 1.010,000 | 1.018,500 |
